Oruka Therapeutics, Inc.
ORKA
$14.51
-$0.925-5.99%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -5.93% | -7.07% | -8.57% | 2,617.25% | -45.50% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 20.64% | 144.80% | -41.13% | 45.54% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -5.70% | -6.58% | -8.74% | 2,354.96% | -39.37% |
|
|||||
Total Current Assets | -5.70% | -6.58% | -8.74% | 2,354.96% | -39.37% |
Net Property, Plant & Equipment | 131.24% | -6.26% | -5.46% | 9.91% | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 139.53% | 0.00% | -98.18% | 383.20% |
Total Assets | -5.22% | -4.77% | -4.36% | 1,952.19% | -28.53% |
|
|||||
Total Accounts Payable | 31.57% | 2.40% | 61.40% | -16.83% | 64,375.00% |
Total Accrued Expenses | -42.95% | -30.83% | 16.13% | -50.48% | 131.49% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 133.22% | 32.86% | 45.89% | 139.34% | -- |
Total Finance Division Other Current Liabilities | 118.30% | -- | -- | 1,686.28% | 246.77% |
Total Other Current Liabilities | 118.30% | -- | -- | 1,686.28% | 246.77% |
Total Current Liabilities | 3.30% | -10.12% | -27.70% | -6.82% | 170.20% |
|
|||||
Total Current Liabilities | 3.30% | -10.12% | -27.70% | -6.82% | 170.20% |
Long-Term Debt | -- | -- | -- | -- | 0.01% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 150.90% | -12.05% | -10.33% | -8.97% | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | 349.07% |
Total Liabilities | 11.21% | -10.23% | -26.92% | -59.16% | 42.86% |
|
|||||
Common Stock & APIC | 0.75% | 0.75% | 16.53% | 117,121.24% | 1,783.33% |
Retained Earnings | -23.47% | -25.08% | -44.49% | -97.62% | -314.30% |
Treasury Stock & Other | -350.00% | 85.37% | -- | -- | -- |
Total Common Equity | -5.83% | -4.61% | 11.74% | 1,271.24% | -310.55% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | -94.74% | 1,802.83% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | -94.74% | 1,802.83% | 0.00% |
|
|||||
Total Common Equity | -5.83% | -4.61% | 11.74% | 1,271.24% | -310.55% |
Total Preferred Equity | 0.00% | 0.00% | -94.74% | 1,802.83% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -5.78% | -4.58% | -3.29% | 1,617.12% | -531.06% |
|